{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:02:19Z","timestamp":1789502539728,"version":"build-2803163510"},"reference-count":217,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:p>Parkinson disease (PD) is the second most common neurodegenerative disorder worldwide, affecting countless patients. Inflammation is a major pathogenic factor in PD. The regulation of inflammation involves multiple processes, including glial cell activation, oxidative stress responses, gut\u2013brain axis signaling, and associated molecular pathways. In recent years, some progress has been made in the study of anti-inflammatory therapies for PD; however, their therapeutic efficacy remains limited. Thus, exploring alternative pharmacological interventions may represent a promising direction for managing inflammation in PD. Traditional Chinese medicine (TCM) has been found to exert therapeutic effects on PD-related inflammation, suggesting that further development of TCM could be beneficial. Therefore, focusing on the discovery and development of TCM-based treatments is worth pursuing. This review summarizes the major active components that show efficacy against PD inflammation and outlines their underlying mechanisms, with the aim of providing new perspectives for identifying alternative therapeutic strategies.<\/jats:p>","DOI":"10.1097\/md.0000000000044392","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:04:24Z","timestamp":1762211064000},"page":"e44392","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The regulatory mechanisms of active ingredients in traditional Chinese medicine for inflammation in Parkinson disease: A review"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8132-2009","authenticated-orcid":false,"given":"Yuxuan","family":"He","sequence":"first","affiliation":[{"name":"Neurology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Neurology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmiao","family":"Ying","sequence":"additional","affiliation":[{"name":"Neurology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiao","family":"Liang","sequence":"additional","affiliation":[{"name":"University of California, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaitian","family":"Yin","sequence":"additional","affiliation":[{"name":"Neurology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[{"name":"Neurology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boqiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Neurology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Neurology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-1535","authenticated-orcid":false,"given":"Yunke","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neurology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"},{"name":"Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","first-page":"223","article-title":"An essay on the shaking palsy.","volume":"14","author":"Parkinson","year":"1817","journal-title":"Med Rep Cases"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity.","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"5","author":"De Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease.","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet (London)"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"106041","DOI":"10.1016\/j.parkreldis.2024.106041","article-title":"Refining the clinical diagnosis of Parkinson\u2019s disease.","volume":"122","author":"Mulroy","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbi.2022.09.010","article-title":"Emerging roles of leptin in Parkinson\u2019s disease: chronic inflammation, neuroprotection and more?","volume":"107","author":"Regensburger","year":"2023","journal-title":"Brain Behav Immun"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review.","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson\u2019s disease.","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"105654","DOI":"10.1016\/j.nbd.2022.105654","article-title":"Upregulation of \u03b1-synuclein following immune activation: possible trigger of Parkinson\u2019s disease.","volume":"166","author":"Kasen","year":"2022","journal-title":"Neurobiol Dis"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"114204","DOI":"10.1016\/j.bbr.2022.114204","article-title":"Targeting \u03b1-synuclein post-translational modifications in Parkinson\u2019s disease.","volume":"439","author":"Canever","year":"2023","journal-title":"Behav Brain Res"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","article-title":"\u03b1-Synuclein in synaptic function and dysfunction.","volume":"46","author":"Sharma","year":"2023","journal-title":"Trends Neurosci"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"115735","DOI":"10.1016\/j.biopha.2023.115735","article-title":"The interplay between \u03b1-Synuclein and NLRP3 inflammasome in Parkinson\u2019s disease.","volume":"168","author":"Huang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains.","volume":"38","author":"Mcgeer","year":"1988","journal-title":"Neurology"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.3390\/ijms22094676","article-title":"The contribution of microglia to neuroinflammation in Parkinson\u2019s disease.","volume":"22","author":"Badanjak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.3390\/ijms23084148","article-title":"Biomarker of neuroinflammation in Parkinson\u2019s disease.","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration.","volume":"19","author":"Patani","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson\u2019s disease.","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"e81890","DOI":"10.7554\/eLife.81890","article-title":"Microglia orchestrate neuroinflammation.","volume":"11","author":"Feldman","year":"2022","journal-title":"Elife"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"105604","DOI":"10.1016\/j.neuint.2023.105604","article-title":"Mitigating neuroinflammation in Parkinson\u2019s disease: exploring the role of proinflammatory cytokines and the potential of phytochemicals as natural therapeutics.","volume":"170","author":"Sharma","year":"2023","journal-title":"Neurochem Int"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease.","volume":"38","author":"Kim","year":"2006","journal-title":"Exp Mol Med"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","article-title":"Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells.","volume":"144","author":"Iovino","year":"2020","journal-title":"J Pharmacol Sci"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jare.2024.01.006","article-title":"Current perspectives on microglia-neuron communication in the central nervous system: direct and indirect modes of interaction.","volume":"66","author":"Hu","year":"2024","journal-title":"J Adv Res"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.conb.2021.09.002","article-title":"Astrocytes and neuropsychiatric symptoms in neurodegenerative diseases: exploring the missing links.","volume":"72","author":"Ben Haim","year":"2022","journal-title":"Curr Opin Neurobiol"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tcb.2023.09.006","article-title":"Astrocyte morphology.","volume":"34","author":"Baldwin","year":"2024","journal-title":"Trends Cell Biol"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration.","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"107813","DOI":"10.1016\/j.intimp.2021.107813","article-title":"The role of TRIM proteins in PRR signaling pathways and immune-related diseases.","volume":"98","author":"Jin","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson\u2019s disease.","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tins.2023.07.005","article-title":"The systemic immune response in Parkinson\u2019s disease: focus on the peripheral immune component.","volume":"46","author":"Lauritsen","year":"2023","journal-title":"Trends Neurosci"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"101618","DOI":"10.1016\/j.arr.2022.101618","article-title":"Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson\u2019s disease.","volume":"78","author":"Kip","year":"2022","journal-title":"Ageing Res Rev"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.3233\/JPD-223237","article-title":"Microglia in Parkinson\u2019s disease.","volume":"12","author":"Stefanova","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"102032","DOI":"10.1016\/j.arr.2023.102032","article-title":"Metabolic reprogramming and polarization of microglia in Parkinson\u2019s disease: role of inflammasome and iron.","volume":"90","author":"Yu","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, iba1.","volume":"57","author":"Ito","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.freeradbiomed.2008.05.026","article-title":"Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: implications for neurodegenerative diseases.","volume":"45","author":"Roy","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"113412","DOI":"10.1016\/j.biopha.2022.113412","article-title":"The role of microglia immunometabolism in neurodegeneration: focus on molecular determinants and metabolic intermediates of metabolic reprogramming.","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"578180","DOI":"10.1016\/j.jneuroim.2023.578180","article-title":"Microglia mediated neuroinflammation in neurodegenerative diseases: a review on the cell signaling pathways involved in microglial activation.","volume":"383","author":"Biswas","year":"2023","journal-title":"J Neuroimmunol"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2009.08.001","article-title":"The influence of microglia on the pathogenesis of Parkinson\u2019s disease.","volume":"89","author":"Long-Smith","year":"2009","journal-title":"Prog Neurobiol"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"e14713","DOI":"10.1016\/j.heliyon.2023.e14713","article-title":"A richer and more diverse future for microglia phenotypes.","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","article-title":"Inflammatory regulators in Parkinson\u2019s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.","volume":"16","author":"Knott","year":"2000","journal-title":"Mol Cell Neurosci"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"815347","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases.","volume":"14","author":"Guo","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"102160","DOI":"10.1016\/j.arr.2023.102160","article-title":"Modulating the polarization phenotype of microglia \u2013 a valuable strategy for central nervous system diseases.","volume":"93","author":"Long","year":"2024","journal-title":"Ageing Res Rev"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions.","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat Neurosci"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology.","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol"},{"key":"R44-20260915","doi-asserted-by":"crossref","first-page":"105080","DOI":"10.1016\/j.neuint.2021.105080","article-title":"A1\/A2 astrocytes in central nervous system injuries and diseases: angels or devils?","volume":"148","author":"Fan","year":"2021","journal-title":"Neurochem Int"},{"key":"R45-20260915","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.it.2007.01.005","article-title":"Astrocytes are active players in cerebral innate immunity.","volume":"28","author":"Farina","year":"2007","journal-title":"Trends Immunol"},{"key":"R46-20260915","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The role of astrocytes in CNS inflammation.","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol"},{"key":"R47-20260915","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","article-title":"Astrocyte crosstalk in CNS inflammation.","volume":"108","author":"Linnerbauer","year":"2020","journal-title":"Neuron"},{"key":"R48-20260915","doi-asserted-by":"crossref","first-page":"176048","DOI":"10.1016\/j.ejphar.2023.176048","article-title":"The \u201cmolecular soldiers\u201d of the CNS: astrocytes, a comprehensive review on their roles and molecular signatures.","volume":"959","author":"Rupareliya","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"R49-20260915","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease.","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"R50-20260915","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.","volume":"119","author":"Brochard","year":"2009","journal-title":"J Clin Invest"},{"key":"R51-20260915","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/brain\/awaa269","article-title":"CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson\u2019s disease.","volume":"143","author":"Galiano-Landeira","year":"2020","journal-title":"Brain"},{"key":"R52-20260915","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/cells10071605","article-title":"B Cells in neuroinflammation: new perspectives and mechanistic insights.","volume":"10","author":"Ahn","year":"2021","journal-title":"Cells"},{"key":"R53-20260915","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.3233\/JPD-223418","article-title":"B lymphocytes in Parkinson\u2019s disease.","volume":"12","author":"Scott","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"R54-20260915","doi-asserted-by":"crossref","first-page":"796288","DOI":"10.3389\/fimmu.2022.796288","article-title":"Gut Microbiota interact with the brain through systemic chronic inflammation: implications on neuroinflammation, neurodegeneration, and aging.","volume":"13","author":"Mou","year":"2022","journal-title":"Front Immunol"},{"key":"R55-20260915","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.3233\/JPD-223152","article-title":"T lymphocytes in Parkinson\u2019s disease.","volume":"12","author":"Contaldi","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"R56-20260915","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.immuni.2023.02.010","article-title":"Toward a general model of CD4+ T cell subset specification and memory cell formation.","volume":"56","author":"Osum","year":"2023","journal-title":"Immunity"},{"key":"R57-20260915","doi-asserted-by":"crossref","first-page":"932152","DOI":"10.3389\/fimmu.2022.932152","article-title":"Th17 cells and inflammation in neurological disorders: possible mechanisms of action.","volume":"13","author":"Shi","year":"2022","journal-title":"Front Immunol"},{"key":"R58-20260915","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study.","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"R59-20260915","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nutres.2022.09.001","article-title":"Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future perspectives.","volume":"107","author":"Coutinho-Wolino","year":"2022","journal-title":"Nutr Res"},{"key":"R60-20260915","doi-asserted-by":"crossref","first-page":"148603","DOI":"10.1016\/j.brainres.2023.148603","article-title":"Active ingredients of Chinese medicine with immunomodulatory properties: NF-\u03baB pathway and Parkinson\u2019s disease.","volume":"1822","author":"Song","year":"2024","journal-title":"Brain Res"},{"key":"R61-20260915","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics.","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"R62-20260915","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The NLRP3 inflammasome: activation and regulation.","volume":"48","author":"Xu","year":"2023","journal-title":"Trends Biochem Sci"},{"key":"R63-20260915","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases.","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R64-20260915","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1517\/13543780903321490","article-title":"The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer.","volume":"18","author":"Yong","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"R65-20260915","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","article-title":"Diversity and versatility of p38 kinase signalling in health and disease.","volume":"22","author":"Canovas","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R66-20260915","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cels.2022.10.003","article-title":"Systematic analysis of the MAPK signaling network reveals MAP3K-driven control of cell fate.","volume":"13","author":"Peterson","year":"2022","journal-title":"Cell Syst"},{"key":"R67-20260915","doi-asserted-by":"crossref","first-page":"115435","DOI":"10.1016\/j.bcp.2023.115435","article-title":"Modulation of p38 MAPK and Nrf2\/HO-1\/NLRP3 inflammasome signaling and pyroptosis outline the anti-neuroinflammatory and remyelinating characters of clemastine in EAE rat model.","volume":"209","author":"Motawi","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"R68-20260915","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1139\/bcb-2022-0371","article-title":"Mitogen- and stress-activated protein kinase (MSK1\/2) regulated gene expression in normal and disease states.","volume":"101","author":"Sattarifard","year":"2023","journal-title":"Biochem Cell Biol"},{"key":"R69-20260915","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1074\/jbc.273.21.12901","article-title":"Induction of Cyclooxygenase-2 by the activated MEKK1 \u2192 SEK1\/MKK4 \u2192 p38 Mitogen-activated protein kinase pathway.","volume":"273","author":"Guan","year":"1998","journal-title":"J Biol Chem"},{"key":"R70-20260915","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1038\/s41598-022-09528-8","article-title":"TIRAP-mediated activation of p38 MAPK in inflammatory signaling.","volume":"12","author":"Rajpoot","year":"2022","journal-title":"Sci Rep"},{"key":"R71-20260915","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1568026054985902","article-title":"The biology of p38 kinase: a central role in inflammation.","volume":"5","author":"Schieven","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"R72-20260915","doi-asserted-by":"crossref","first-page":"635636","DOI":"10.3389\/fcell.2021.635636","article-title":"The p38(MAPK)-MK2 signaling axis as a critical link between inflammation and synaptic transmission.","volume":"9","author":"Beamer","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R73-20260915","doi-asserted-by":"crossref","first-page":"115973","DOI":"10.1016\/j.bcp.2023.115973","article-title":"Function and inhibition of P38 MAP kinase signaling: targeting multiple inflammation diseases.","volume":"220","author":"Wang","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"R74-20260915","doi-asserted-by":"crossref","first-page":"106210","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases.","volume":"80","author":"Xin","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R75-20260915","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic.","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R76-20260915","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","article-title":"Inhibition of the JAK\/STAT pathway protects against \u03b1-synuclein-induced neuroinflammation and dopaminergic neurodegeneration.","volume":"36","author":"Qin","year":"2016","journal-title":"J Neurosci"},{"key":"R77-20260915","doi-asserted-by":"crossref","first-page":"577758","DOI":"10.1016\/j.jneuroim.2021.577758","article-title":"The involvement of JAK\/STAT signaling pathway in the treatment of Parkinson\u2019s disease.","volume":"361","author":"Lashgari","year":"2021","journal-title":"J Neuroimmunol"},{"key":"R78-20260915","doi-asserted-by":"crossref","first-page":"1110765","DOI":"10.3389\/fbioe.2023.1110765","article-title":"JAK\/STAT pathway: extracellular signals, diseases, immunity, and therapeutic regimens.","volume":"11","author":"Hu","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"R79-20260915","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.3390\/jcm12082865","article-title":"The use of JAK\/STAT inhibitors in chronic inflammatory disorders.","volume":"12","author":"Caiazzo","year":"2023","journal-title":"J Clin Med"},{"key":"R80-20260915","doi-asserted-by":"crossref","first-page":"102750","DOI":"10.1016\/j.autrev.2021.102750","article-title":"Working and safety profiles of JAK\/STAT signaling inhibitors. Are these small molecules also smart?","volume":"20","author":"Favoino","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R81-20260915","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"R82-20260915","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","article-title":"Redox metabolism: ROS as specific molecular regulators of cell signaling and function.","volume":"81","author":"Lennicke","year":"2021","journal-title":"Mol Cell"},{"key":"R83-20260915","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson\u2019s disease: is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp Neurol"},{"key":"R84-20260915","doi-asserted-by":"crossref","first-page":"105851","DOI":"10.1016\/j.nbd.2022.105851","article-title":"Oxidative stress and synaptic dysfunction in rodent models of Parkinson\u2019s disease.","volume":"173","author":"Imbriani","year":"2022","journal-title":"Neurobiol Dis"},{"key":"R85-20260915","doi-asserted-by":"crossref","first-page":"114811","DOI":"10.1016\/j.bbr.2023.114811","article-title":"Mitochondrial homeostasis regulation: a promising therapeutic target for Parkinson\u2019s disease.","volume":"459","author":"Yao","year":"2024","journal-title":"Behav Brain Res"},{"key":"R86-20260915","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease.","volume":"106\u2013107","author":"Subramaniam","year":"2013","journal-title":"Prog Neurobiol"},{"key":"R87-20260915","doi-asserted-by":"crossref","first-page":"107122","DOI":"10.1016\/j.bpc.2023.107122","article-title":"The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson\u2019s disease.","volume":"303","author":"Li","year":"2023","journal-title":"Biophys Chem"},{"key":"R88-20260915","doi-asserted-by":"crossref","first-page":"101263","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in Parkinson\u2019s disease.","volume":"67","author":"Dion\u00edsio","year":"2021","journal-title":"Ageing Res Rev"},{"key":"R89-20260915","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic Parkinsonism.","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol Dis"},{"key":"R90-20260915","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson\u2019s disease.","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem Int"},{"key":"R91-20260915","doi-asserted-by":"crossref","first-page":"105014","DOI":"10.1016\/j.neuint.2021.105014","article-title":"Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson\u2019s disease: the therapeutic role of Nrf2 activators.","volume":"145","author":"Jayaram","year":"2021","journal-title":"Neurochem Int"},{"key":"R92-20260915","doi-asserted-by":"crossref","first-page":"102389","DOI":"10.1016\/j.redox.2022.102389","article-title":"Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway.","volume":"54","author":"Liu","year":"2022","journal-title":"Redox Biol"},{"key":"R93-20260915","doi-asserted-by":"crossref","first-page":"101756","DOI":"10.1016\/j.arr.2022.101756","article-title":"Role of Nrf2 in aging, Alzheimer\u2019s and other neurodegenerative diseases.","volume":"82","author":"George","year":"2022","journal-title":"Ageing Res Rev"},{"key":"R94-20260915","doi-asserted-by":"crossref","first-page":"115998","DOI":"10.1016\/j.ejmech.2023.115998","article-title":"Recent progress and applications of small molecule inhibitors of Keap1\u2013Nrf2 axis for neurodegenerative diseases.","volume":"264","author":"Wang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"R95-20260915","doi-asserted-by":"crossref","first-page":"105325","DOI":"10.1016\/j.neuint.2022.105325","article-title":"The principal molecular mechanisms behind the activation of Keap1\/Nrf2\/ARE pathway leading to neuroprotective action in Parkinson\u2019s disease.","volume":"156","author":"Chakkittukandiyil","year":"2022","journal-title":"Neurochem Int"},{"key":"R96-20260915","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation.","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"key":"R97-20260915","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbamcr.2008.01.002","article-title":"NF-\u03baB\/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK.","volume":"1783","author":"Liu","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"R98-20260915","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.biopha.2018.10.019","article-title":"Crosstalk of toll-like receptors signaling and Nrf2 pathway for regulation of inflammation.","volume":"108","author":"Mohan","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R99-20260915","doi-asserted-by":"crossref","first-page":"101915","DOI":"10.1016\/j.arr.2023.101915","article-title":"Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson\u2019s disease.","volume":"87","author":"Rajan","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R100-20260915","doi-asserted-by":"crossref","first-page":"101812","DOI":"10.1016\/j.arr.2022.101812","article-title":"Role of enteric glia and microbiota-gut-brain axis in Parkinson disease pathogenesis.","volume":"84","author":"Claudino Dos Santos","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R101-20260915","doi-asserted-by":"crossref","first-page":"101802","DOI":"10.1016\/j.smim.2023.101802","article-title":"The gut-brain vascular axis in neuroinflammation.","volume":"69","author":"Carloni","year":"2023","journal-title":"Semin Immunol"},{"key":"R102-20260915","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnins.2018.00049","article-title":"The vagus nerve at the interface of the microbiota-gut-brain axis.","volume":"12","author":"Bonaz","year":"2018","journal-title":"Front Neurosci"},{"key":"R103-20260915","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease.","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"R104-20260915","doi-asserted-by":"crossref","first-page":"102171","DOI":"10.1016\/j.arr.2023.102171","article-title":"Does gut brain axis has an impact on Parkinson\u2019s disease (PD)?","volume":"94","author":"Elangovan","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R105-20260915","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3390\/jcm10061299","article-title":"Gut microbiota interaction with the central nervous system throughout life.","volume":"10","author":"Ojeda","year":"2021","journal-title":"J Clin Med"},{"key":"R106-20260915","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajpath.2021.09.006","article-title":"Chronic intestinal inflammation suppresses brain activity by inducing neuroinflammation in mice.","volume":"192","author":"Mitchell","year":"2022","journal-title":"Am J Pathol"},{"key":"R107-20260915","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41531-021-00170-1","article-title":"Is LRRK2 the missing link between inflammatory bowel disease and Parkinson\u2019s disease?","volume":"7","author":"Herrick","year":"2021","journal-title":"NPJ Parkinson's Dis"},{"key":"R108-20260915","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1126\/science.abi6087","article-title":"Signaling inflammation across the gut-brain axis.","volume":"374","author":"Agirman","year":"2021","journal-title":"Science"},{"key":"R109-20260915","doi-asserted-by":"crossref","first-page":"101857","DOI":"10.1016\/j.arr.2023.101857","article-title":"Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases.","volume":"85","author":"Cheng","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R110-20260915","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neurol.2023.11.004","article-title":"The gut-brain axis in Parkinson\u2019s disease.","volume":"180","author":"Bonaz","year":"2024","journal-title":"Rev Neurol (Paris)"},{"key":"R111-20260915","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41385-022-00514-x","article-title":"Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury.","volume":"15","author":"Rath","year":"2022","journal-title":"Mucosal Immunol"},{"key":"R112-20260915","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.14798","article-title":"Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival.","volume":"1514","author":"Kuo","year":"2022","journal-title":"Ann N Y Acad Sci"},{"key":"R113-20260915","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota axis in Parkinson\u2019s disease.","volume":"21","author":"Mulak","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R114-20260915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","article-title":"The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis?","volume":"3","author":"Houser","year":"2017","journal-title":"NPJ Parkinson's Dis"},{"key":"R115-20260915","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tem.2021.11.005","article-title":"Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson\u2019s disease.","volume":"33","author":"Anis","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"R116-20260915","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.parkreldis.2018.09.032","article-title":"A punch in the gut \u2013 intestinal inflammation links environmental factors to neurodegeneration in Parkinson\u2019s disease.","volume":"60","author":"Becker","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"R117-20260915","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2020.02.030","article-title":"The link between gut dysbiosis and neuroinflammation in Parkinson\u2019s disease.","volume":"432","author":"Baizabal-Carvallo","year":"2020","journal-title":"Neuroscience"},{"key":"R118-20260915","doi-asserted-by":"crossref","first-page":"102684","DOI":"10.1016\/j.autrev.2020.102684","article-title":"Parkinson\u2019s disease is an autoimmune disease: a reappraisal.","volume":"19","author":"Bonam","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R119-20260915","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: autoimmunity and neuroinflammation.","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R120-20260915","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between Parkinson disease and autoimmune diseases.","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol"},{"key":"R121-20260915","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system \u2014 associations, mechanisms and therapeutics.","volume":"16","author":"Tan","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"R122-20260915","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2019.00303","article-title":"Autoimmunity in Parkinson\u2019s disease: the role of \u03b1-synuclein-specific T cells.","volume":"10","author":"Garretti","year":"2019","journal-title":"Front Immunol"},{"key":"R123-20260915","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.3390\/molecules27248777","article-title":"Recent advances in natural polyphenol research.","volume":"27","author":"Dini","year":"2022","journal-title":"Molecules"},{"key":"R124-20260915","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.intimp.2017.06.004","article-title":"Hyperoside inhibits lipopolysaccharide-induced inflammatory responses in microglial cells via p38 and NF\u03baB pathways.","volume":"50","author":"Fan","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"R125-20260915","doi-asserted-by":"crossref","first-page":"102010","DOI":"10.1016\/j.redox.2021.102010","article-title":"Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy.","volume":"44","author":"Han","year":"2021","journal-title":"Redox Biol"},{"key":"R126-20260915","doi-asserted-by":"crossref","first-page":"e16195","DOI":"10.1016\/j.heliyon.2023.e16195","article-title":"Curcumin protects against rotenone-induced Parkinson\u2019s disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction.","volume":"9","author":"Xu","year":"2023","journal-title":"Heliyon"},{"key":"R127-20260915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","article-title":"Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson\u2019s disease in rats.","volume":"600","author":"Jin","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R128-20260915","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2016.03.023","article-title":"Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson\u2019s disease.","volume":"251","author":"Gaballah","year":"2016","journal-title":"Chem Biol Interact"},{"key":"R129-20260915","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fnmol.2017.00441","article-title":"Icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation in vivo and in vitro.","volume":"10","author":"Wang","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"R130-20260915","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cbi.2017.03.016","article-title":"Protective role of apigenin on rotenone induced rat model of Parkinson\u2019s disease: suppression of neuroinflammation and oxidative stress mediated apoptosis.","volume":"269","author":"Anusha","year":"2017","journal-title":"Chem Biol Interact"},{"key":"R131-20260915","doi-asserted-by":"crossref","first-page":"105221","DOI":"10.1016\/j.neuint.2021.105221","article-title":"Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson\u2019s disease via inhibiting p38MAPK\/NF-\u03baB signaling pathway.","volume":"152","author":"Cai","year":"2022","journal-title":"Neurochem Int"},{"key":"R132-20260915","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","article-title":"Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.","volume":"15","author":"Han","year":"2019","journal-title":"Autophagy"},{"key":"R133-20260915","doi-asserted-by":"crossref","first-page":"104140","DOI":"10.1016\/j.jff.2020.104140","article-title":"Antioxidant, anti-inflammatory and neuroprotective effect of kaempferol on rotenone-induced Parkinson\u2019s disease model of rats and SH-S5Y5 cells by preventing loss of tyrosine hydroxylase.","volume":"74","author":"Pan","year":"2020","journal-title":"J Funct Foods"},{"key":"R134-20260915","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuro.2022.03.004","article-title":"Neuroprotective effects of catechin and quercetin in experimental Parkinsonism through modulation of dopamine metabolism and expression of IL-1\u03b2, TNF-\u03b1, NF-\u03baB, I\u03baKB, and p53 genes in male wistar rats.","volume":"90","author":"Josiah","year":"2022","journal-title":"Neurotoxicology"},{"key":"R135-20260915","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12640-019-00143-6","article-title":"Protective effect of (\u2212)Epigallocatechin-3-gallate on rotenone-induced Parkinsonism-like symptoms in rats.","volume":"37","author":"Tseng","year":"2020","journal-title":"Neurotox Res"},{"key":"R136-20260915","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2008.10.046","article-title":"Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation.","volume":"448","author":"Chen","year":"2008","journal-title":"Neurosci Lett"},{"key":"R137-20260915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13880209.2021.2006723","article-title":"The pharmacological properties and corresponding mechanisms of farrerol: a comprehensive review.","volume":"60","author":"Qin","year":"2022","journal-title":"Pharm Biol"},{"key":"R138-20260915","doi-asserted-by":"crossref","first-page":"105739","DOI":"10.1016\/j.intimp.2019.105739","article-title":"Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson\u2019s disease by suppressing the activation of the AKT and NF-\u03baB signaling pathways.","volume":"75","author":"Li","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"R139-20260915","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/ijms19010012","article-title":"Galangin reduces the loss of dopaminergic neurons in an LPS-evoked model of Parkinson\u2019s disease in rats.","volume":"19","author":"Chen","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R140-20260915","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3390\/nu14122387","article-title":"Hesperidin: a review on extraction methods, stability and biological activities.","volume":"14","author":"Pyrzynska","year":"2022","journal-title":"Nutrients"},{"key":"R141-20260915","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s12035-020-01940-3","article-title":"Hesperidin ameliorates anxiety-depressive-like behavior in 6-OHDA model of Parkinson\u2019s disease by regulating striatal cytokine and neurotrophic factors levels and dopaminergic innervation loss in the striatum of mice.","volume":"57","author":"Antunes","year":"2020","journal-title":"Mol Neurobiol"},{"key":"R142-20260915","doi-asserted-by":"crossref","first-page":"106188","DOI":"10.1016\/j.psyneuen.2023.106188","article-title":"Dietary flavonoid isoliquiritigenin inhibits microglia-mediated neuroinflammation in Parkinson\u2019s disease models via JNK\/NF\u03baB\/AKT signaling pathway.","volume":"153","author":"Huang","year":"2023","journal-title":"Psychoneuroendocrinology"},{"key":"R143-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-011-9295-2","article-title":"Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson\u2019s disease.","volume":"22","author":"Moshahid Khan","year":"2012","journal-title":"Neurotox Res"},{"key":"R144-20260915","doi-asserted-by":"crossref","first-page":"119921","DOI":"10.1016\/j.lfs.2021.119921","article-title":"Ferulic acid: a review of its pharmacology, pharmacokinetics and derivatives.","volume":"284","author":"Li","year":"2021","journal-title":"Life Sci"},{"key":"R145-20260915","first-page":"5499","article-title":"Neuroprotective potential of ferulic acid in the rotenone model of Parkinson\u2019s disease.","volume":"9","author":"Ojha","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"R146-20260915","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.3390\/molecules27248819","article-title":"Phloretin, as a potent anticancer compound: from chemistry to cellular interactions.","volume":"27","author":"Tuli","year":"2022","journal-title":"Molecules"},{"key":"R147-20260915","doi-asserted-by":"crossref","first-page":"116600","DOI":"10.1016\/j.lfs.2019.116600","article-title":"Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson\u2019s disease in mice.","volume":"232","author":"Zhang","year":"2019","journal-title":"Life Sci"},{"key":"R148-20260915","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.3390\/ijms231810578","article-title":"Anti-inflammatory and neuroprotective effects of morin in an MPTP-induced Parkinson\u2019s disease model.","volume":"23","author":"Hong","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R149-20260915","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00210-022-02373-6","article-title":"Mangiferin: the miraculous xanthone with diverse pharmacological properties.","volume":"396","author":"Dutta","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R150-20260915","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/09727531211051976","article-title":"Pharmacological, biochemical and immunological studies on protective effect of mangiferin in 6-Hydroxydopamine (6-OHDA)-induced Parkinson\u2019s disease in rats.","volume":"28","author":"Tiwari","year":"2021","journal-title":"Ann Neurosci"},{"key":"R151-20260915","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/jmf.2014.3241","article-title":"Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson\u2019s disease.","volume":"18","author":"Jeong","year":"2015","journal-title":"J Med Food"},{"key":"R152-20260915","doi-asserted-by":"crossref","first-page":"105613","DOI":"10.1016\/j.neuint.2023.105613","article-title":"The citrus flavonoid, nobiletin inhibits neuronal inflammation by preventing the activation of NF-\u03baB.","volume":"171","author":"Murata","year":"2023","journal-title":"Neurochem Int"},{"key":"R153-20260915","doi-asserted-by":"crossref","first-page":"105817","DOI":"10.1016\/j.bioorg.2022.105817","article-title":"Natural terpenoids with anti-inflammatory activities: potential leads for anti-inflammatory drug discovery.","volume":"124","author":"Ge","year":"2022","journal-title":"Bioorg Chem"},{"key":"R154-20260915","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","article-title":"Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease.","volume":"91","author":"Ahmed","year":"2021","journal-title":"Brain Behav Immun"},{"key":"R155-20260915","doi-asserted-by":"crossref","first-page":"e04121","DOI":"10.1016\/j.heliyon.2020.e04121","article-title":"Phytochemical andrographolide modulates NF-\u03baB and JNK in human neuroblastoma SH-SY5Y cells, a cell model for Parkinson\u2019s disease.","volume":"6","author":"Ketterman","year":"2020","journal-title":"Heliyon"},{"key":"R156-20260915","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pbb.2014.03.028","article-title":"Neuroprotective effects of the andrographolide analogue AL-1 in the MPP+\/MPTP-induced Parkinson\u2019s disease model in vitro and in mice.","volume":"122","author":"Zhang","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"R157-20260915","doi-asserted-by":"crossref","first-page":"105651","DOI":"10.1016\/j.intimp.2019.05.036","article-title":"Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson\u2019s disease mouse model.","volume":"75","author":"Yang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"R158-20260915","doi-asserted-by":"crossref","first-page":"631501","DOI":"10.3389\/fnins.2021.631501","article-title":"Astragaloside IV protects 6-hydroxydopamine-induced SH-SY5Y cell model of Parkinson\u2019s disease via activating the JAK2\/STAT3 pathway.","volume":"15","author":"Xu","year":"2021","journal-title":"Front Neurosci"},{"key":"R159-20260915","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10529-013-1192-8","article-title":"Paeoniflorin, a monoterpene glycoside, attenuates lipopolysaccharide-induced neuronal injury and brain microglial inflammatory response.","volume":"35","author":"Nam","year":"2013","journal-title":"Biotechnol Lett"},{"key":"R160-20260915","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.bjp.0706732","article-title":"Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease by activation of adenosine A1 receptor.","volume":"148","author":"Hua-Qing","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R161-20260915","doi-asserted-by":"crossref","first-page":"102189","DOI":"10.1016\/j.pbi.2022.102189","article-title":"Tanshinones: leading the way into lamiaceae labdane-related diterpenoid biosynthesis.","volume":"66","author":"Wang","year":"2022","journal-title":"Curr Opin Plant Biol"},{"key":"R162-20260915","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jep.2015.01.042","article-title":"Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson\u2019s disease.","volume":"164","author":"Wang","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"R163-20260915","doi-asserted-by":"crossref","first-page":"104269","DOI":"10.1016\/j.arabjc.2022.104269","article-title":"Neuroprotective effects of tanshinone IIA in experimental model of Parkinson disease in rats.","volume":"15","author":"Zhang","year":"2022","journal-title":"Arabian J Chem"},{"key":"R164-20260915","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jns.2014.11.026","article-title":"Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson\u2019s disease.","volume":"348","author":"Ren","year":"2015","journal-title":"J Neurol Sci"},{"key":"R165-20260915","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jare.2024.01.003","article-title":"Rare ginsenosides: a unique perspective of ginseng research.","volume":"66","author":"Fan","year":"2024","journal-title":"J Adv Res"},{"key":"R166-20260915","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.intimp.2015.10.032","article-title":"Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced mouse model of Parkinson\u2019s disease.","volume":"29","author":"Zhou","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"R167-20260915","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.toxlet.2015.12.005","article-title":"Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced Parkinsonism mouse model by targeting \u03b1-synuclein abnormalities in the substantia nigra.","volume":"243","author":"Heng","year":"2016","journal-title":"Toxicol Lett"},{"key":"R168-20260915","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41401-020-0358-x","article-title":"Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-\u03baB signaling and modulation of M1\/M2 polarization.","volume":"41","author":"Jia-Qi","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"R169-20260915","first-page":"383","article-title":"Ginsenoside Rb1 attenuates lipopolysaccharide-induced chronic neuroinflammation in mice by tuning glial cell polarization.","volume":"9","author":"Liu","year":"2022","journal-title":"J Tradit Chin Med Sci"},{"key":"R170-20260915","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4103\/1673-5374.257536","article-title":"Ginsenoside Rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection.","volume":"14","author":"Da-Wei","year":"2019","journal-title":"Neural Regener Res"},{"key":"R171-20260915","doi-asserted-by":"crossref","first-page":"106679","DOI":"10.1016\/j.intimp.2020.106679","article-title":"Menthol protects dopaminergic neurons against inflammation-mediated damage in lipopolysaccharide (LPS)-Evoked model of Parkinson\u2019s disease.","volume":"85","author":"Du","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R172-20260915","doi-asserted-by":"crossref","first-page":"577806","DOI":"10.1016\/j.jneuroim.2022.577806","article-title":"The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson\u2019 disease mice.","volume":"364","author":"Miao","year":"2022","journal-title":"J Neuroimmunol"},{"key":"R173-20260915","doi-asserted-by":"crossref","first-page":"119481","DOI":"10.1016\/j.jns.2021.119481","article-title":"The protective effect of Ginkgolide B on MPTP-induced Parkinson mice.","volume":"429","author":"Yin","year":"2021","journal-title":"J Neurol Sci"},{"key":"R174-20260915","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2018.04.006","article-title":"Triptolide up-regulates metabotropic glutamate receptor 5 to inhibit microglia activation in the lipopolysaccharide-induced model of Parkinson\u2019s disease.","volume":"71","author":"Huang","year":"2018","journal-title":"Brain Behav Immun"},{"key":"R175-20260915","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jneuroim.2003.10.054","article-title":"Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation.","volume":"148","author":"Li","year":"2004","journal-title":"J Neuroimmunol"},{"key":"R176-20260915","doi-asserted-by":"crossref","first-page":"100641","DOI":"10.1016\/j.bbih.2023.100641","article-title":"HMGB1 in depression: an overview of microglial HMBG1 in the pathogenesis of depression.","volume":"30","author":"Huang","year":"2023","journal-title":"Brain Behav Immun Health"},{"key":"R177-20260915","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2016.02.018","article-title":"In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson\u2019s disease which can be attenuated by glycyrrhizin.","volume":"91","author":"Santoro","year":"2016","journal-title":"Neurobiol Dis"},{"key":"R178-20260915","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12640-015-9579-z","article-title":"Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson\u2019s disease.","volume":"29","author":"Ojha","year":"2016","journal-title":"Neurotox Res"},{"key":"R179-20260915","doi-asserted-by":"crossref","first-page":"115234","DOI":"10.1016\/j.jep.2022.115234","article-title":"Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson\u2019s disease like pathology in Zebrafish.","volume":"292","author":"Ren","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"R180-20260915","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","article-title":"Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson\u2019s disease.","volume":"64","author":"G\u00f3mez-G\u00e1lvez","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R181-20260915","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.4049\/jimmunol.1102435","article-title":"Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation.","volume":"187","author":"Chung","year":"2011","journal-title":"J Immunol"},{"key":"R182-20260915","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1007\/s11064-021-03431-w","article-title":"Berberine attenuates MPP+-induced neuronal injury by regulating LINC00943\/miR-142-5p\/KPNA4\/NF-\u03baB pathway in SK-N-SH cells.","volume":"46","author":"Li","year":"2021","journal-title":"Neurochem Res"},{"key":"R183-20260915","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jnutbio.2012.03.018","article-title":"Anti-apoptotic and anti-inflammatory effect of Piperine on 6-OHDA induced Parkinson\u2019s rat model.","volume":"24","author":"Shrivastava","year":"2013","journal-title":"J Nutr Biochem"},{"key":"R184-20260915","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12640-019-00120-z","article-title":"Neuroprotective effect of Quercetin in Combination with Piperine against rotenone- and iron supplement\u2013induced Parkinson\u2019s disease in experimental rats.","volume":"37","author":"Sharma","year":"2020","journal-title":"Neurotox Res"},{"key":"R185-20260915","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2174\/1389200221666200610172105","article-title":"Salidroside \u2013 can it be a multifunctional drug?","volume":"21","author":"Magani","year":"2020","journal-title":"Curr Drug Metab"},{"key":"R186-20260915","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.18632\/aging.103215","article-title":"Salidroside ameliorates Parkinson\u2019s disease by inhibiting NLRP3-dependent pyroptosis.","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"R187-20260915","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lfs.2006.09.010","article-title":"Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.","volume":"80","author":"Tian","year":"2006","journal-title":"Life Sci"},{"key":"R188-20260915","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2015.04.037","article-title":"\u03b1-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson\u2019s disease.","volume":"97","author":"Kim","year":"2015","journal-title":"Neuropharmacology"},{"key":"R189-20260915","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/00207454.2019.1573171","article-title":"Osthole alleviates MPTP-induced Parkinson\u2019s disease mice by suppressing Notch signaling pathway.","volume":"129","author":"Wang","year":"2019","journal-title":"Int J Neurosci"},{"key":"R190-20260915","doi-asserted-by":"crossref","first-page":"110820","DOI":"10.1016\/j.cbi.2023.110820","article-title":"Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson\u2019s disease.","volume":"387","author":"Huang","year":"2024","journal-title":"Chem Biol Interact"},{"key":"R191-20260915","doi-asserted-by":"crossref","first-page":"107725","DOI":"10.1016\/j.intimp.2021.107725","article-title":"Baicalin protects LPS-induced blood\u2013brain barrier damage and activates Nrf2-mediated antioxidant stress pathway.","volume":"96","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R192-20260915","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12974-019-1472-x","article-title":"Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner.","volume":"16","author":"Zhang","year":"2019","journal-title":"J Neuroinflammation"},{"key":"R193-20260915","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/tnsci-2022-0239","article-title":"Isoliquiritigenin attenuates neuroinflammation in mice model of Parkinson\u2019s disease by promoting Nrf2\/NQO-1 pathway.","volume":"13","author":"Huang","year":"2022","journal-title":"Transl Neurosci"},{"key":"R194-20260915","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s12640-022-00521-7","article-title":"Apigenin attenuates functional and structural alterations via targeting NF-kB\/Nrf2 signaling pathway in LPS-induced Parkinsonism in experimental rats.","volume":"40","author":"Patel","year":"2022","journal-title":"Neurotox Res"},{"key":"R195-20260915","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/01480545.2018.1504961","article-title":"Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson\u2019s disease and inflammatory pathways.","volume":"43","author":"Elmazoglu","year":"2020","journal-title":"Drug Chem Toxicol"},{"key":"R196-20260915","doi-asserted-by":"crossref","first-page":"887407","DOI":"10.3389\/fcimb.2022.887407","article-title":"Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson\u2019s disease.","volume":"12","author":"Cui","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R197-20260915","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/ph16010039","article-title":"Exploring the neuroprotective mechanism of curcumin inhibition of intestinal inflammation against Parkinson\u2019s disease based on the gut-brain axis.","volume":"16","author":"Zhong","year":"2023","journal-title":"Pharmaceuticals"},{"key":"R198-20260915","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/jsfa.11458","article-title":"Resveratrol regulates intestinal barrier function in cyclophosphamide-induced immunosuppressed mice.","volume":"102","author":"Song","year":"2022","journal-title":"J Sci Food Agric"},{"key":"R199-20260915","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1039\/D2FO03379H","article-title":"The protective role of microbiota in the prevention of MPTP\/P-induced Parkinson\u2019s disease by resveratrol.","volume":"14","author":"Tao","year":"2023","journal-title":"Food Funct"},{"key":"R200-20260915","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.apsb.2021.03.020","article-title":"Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4\/MyD88\/NF-\u03baB pathway through microbiota\u2013gut\u2013brain axis.","volume":"11","author":"Zhao","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"R201-20260915","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1089\/jmf.2019.4640","article-title":"Korean red ginseng regulates intestinal tight junction and inflammation in the colon of a Parkinson\u2019s disease mouse model.","volume":"23","author":"Jeon","year":"2020","journal-title":"J Med Food"},{"key":"R202-20260915","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1871523021666220328121721","article-title":"Diosgenin: mechanistic insights on its anti-inflammatory effects.","volume":"21","author":"Karami-Mohajeri","year":"2022","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"R203-20260915","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","article-title":"The brain-gut-microbiome axis.","volume":"6","author":"Martin","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R204-20260915","doi-asserted-by":"crossref","first-page":"108311","DOI":"10.1016\/j.pharmthera.2022.108311","article-title":"Bile acids and neurological disease.","volume":"240","author":"Hurley","year":"2022","journal-title":"Pharmacol Ther"},{"key":"R205-20260915","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jpha.2023.06.007","article-title":"Protective effects of dioscin against Parkinson\u2019s disease via regulating bile acid metabolism through remodeling gut microbiome\/GLP-1 signaling.","volume":"13","author":"Mao","year":"2023","journal-title":"J Pharm Anal"},{"key":"R206-20260915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jff.2014.08.019","article-title":"Immunomodulatory activities of polysaccharides from Chlorella pyrenoidosa in a mouse model of Parkinson\u2019s disease.","volume":"11","author":"Chen","year":"2014","journal-title":"J Funct Foods"},{"key":"R207-20260915","doi-asserted-by":"crossref","first-page":"147958","DOI":"10.1016\/j.brainres.2022.147958","article-title":"Morin ameliorates rotenone-induced Parkinson disease in mice through antioxidation and anti-neuroinflammation: gut-brain axis involvement.","volume":"1789","author":"Ishola","year":"2022","journal-title":"Brain Res"},{"key":"R208-20260915","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12272-013-0051-4","article-title":"Neurotoxic effects of berberine on long-term l-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease.","volume":"36","author":"Shin","year":"2013","journal-title":"Arch Pharm Res"},{"key":"R209-20260915","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/ptr.5893","article-title":"Toxicological effects of (Licorice): a review.","volume":"31","author":"Nazari","year":"2017","journal-title":"Phytother Res"},{"key":"R210-20260915","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2014.06.006","article-title":"Triptolide: progress on research in pharmacodynamics and toxicology.","volume":"155","author":"Li","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"R211-20260915","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/ijms21062084","article-title":"Potential adverse effects of resveratrol: a literature review.","volume":"21","author":"Shaito","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R212-20260915","doi-asserted-by":"crossref","first-page":"7965433","DOI":"10.1155\/2022\/7965433","article-title":"Mechanisms of autoimmune cell in DA neuron apoptosis of Parkinson\u2019s disease: recent advancement.","volume":"2022","author":"Zheng","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"R213-20260915","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.10.004","article-title":"Novel tactics for neuroprotection in Parkinson\u2019s disease: role of antibiotics, polyphenols and neuropeptides.","volume":"155","author":"Reglodi","year":"2017","journal-title":"Prog Neurobiol"},{"key":"R214-20260915","doi-asserted-by":"crossref","first-page":"115788","DOI":"10.1016\/j.biopha.2023.115788","article-title":"Flavonoids: their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson\u2019s disease.","volume":"168","author":"A\u00e7ar","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R215-20260915","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ptr.5246","article-title":"Neuroprotection by saponins.","volume":"29","author":"Sun","year":"2015","journal-title":"Phytother Res"},{"key":"R217-20260915","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s13287-022-03050-4","article-title":"The potential use of mesenchymal stem cells and their exosomes in Parkinson\u2019s disease treatment.","volume":"13","author":"Heris","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"R218-20260915","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00702-020-02167-1","article-title":"Parkinson\u2019s disease treatment: past, present, and future.","volume":"127","author":"Elsworth","year":"2020","journal-title":"J Neural Transm (Vienna)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:03:28Z","timestamp":1789499008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":217,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044392","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2024-06-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}